The 15th VICH Steering Committee meeting determines the strategy for
VICH until 2010 and finalises the VICH3 conference programme
The VICH Steering Committee determined its 5-year strategy 2006-2010 during its 15th
meeting on 19 and 20 October 2023 in Berlin. VICH strategy will continue to include the
development of new Guidelines; increased emphasis will however be put on a cost/benefit
analysis. The Steering Committee recognised moreover that regular monitoring and updating
of the implemented Guidelines will become more important.
An important step was achieved by the sign-off of the Phase II Environmental Risk
Assessment - Ecotoxicity Guideline at step 6, VICH Guideline 38 (Environmental Impact
assessment – Phase II), for implementation in the 3 regions by October 2005.
The Steering Committee congratulated the members and the chairman of the Expert Working
Group for the successful conclusion of 2 VICH Ecotoxicity Guidelines and the sustained
commitment to this difficult task.
The Steering Committee also signed off the first draft Target Animal Safety Guideline at step
4, VICH GL 41 (Reversion to Virulence – Examination of live Veterinary Vaccines in Target
Animals for Absence of Reversion to Virulence), which was released for a 6-month public
The Steering Committee confirmed the direction for the Pharmacovigilance activities and
reviewed the work of the Expert Working Groups on Quality, Target Animal Safety and
Biologicals Quality Monitoring.
The Steering Committee finalised the programme of the VICH3 international conference
which will be hosted by the USA on 26 & 27 May 2023 in Washington DC. The programme
will focus on some of the 41 Guidelines that have been published in draft form or as final
Guidelines since the creation of VICH in 1996. VICH’s strategy for future achievements in
2006-2010 will also be an important discussion topic of the conference.
Participants to the conference are therefore warmly welcomed to take part in the exchanges
of information which will take place in special Focus sessions where the following VICH topics
will be addressed: Ecotoxicity, Biologicals Quality Monitoring, Quality, Safety,
Pharmacovigilance, Antimicrobial Resistance and Target Animal Safety.
FDA Acting Commissioner, Dr L. Crawford, will open the conference and key-note speaker Dr
P. Lichtinger, President of Pfizer Animal Health, will address the Industry perspective of global
trends in Veterinary Medicine.
The 16th meeting of the Steering Committee is scheduled for 24, 25 and 28 May 2005, in
Washington DC (USA).
MEMBERS OF THE STEERING COMMITTEE
EU: European Commission - European Agency for the Evaluation of Medicinal Products
JMAFF: Japanese Ministry of Agriculture, Forestry and Fisheries
USA: US Food & Drug Administration – Center for Veterinary Medicine (CVM) and US Department of Agriculture
– Center for Veterinary Biologics (USDA/CVB)
AHI: US Animal Health Institute
IFAH-EUROPE: Representing the European Animal Health Industry
JVPA: Japanese Veterinary Products Association
Australia/New Zealand: Australian Pesticides and Veterinary Medicines Authority (APVMA)/New Zealand Food
Safety Authority (NZFSA)
Avcare/AGCARM: National Association for Crop Production & Animal Health (Australia)/Agricultural
Chemicals & Animal Remedies Manufacturers’ Association of New Zealand
Canada: Health Canada (HC) - Veterinary Drugs Directorate (VDD) and Canadian Food Inspection Agency
(CFIA) - Veterinary Biologics Section (VBS)
CAHI: Canadian Animal Health Institute
OIE: International Office of Epizootics
AVBC: Association of Veterinary Biologics Companies (USA)
CAMEVET: Representing Authorities and Industry Associations from Latin American countries
For further information, please contact the VICH Secretariat:
c/o IFAH, International Federation for Animal Health
Rue Defacqz, 1 - 1000 Brussels (Belgium)